25 September 2019
Room 213 Room 220 Room 221
9:30-11:30 Thailand Genomics Roadmap 9.30-10.40 Trends & Opportunities in Digital Health Market 9:30-10:50 Partnering Opportunities with Asian Investors: What Asian Investors are looking for?
·   IQVIA Thailand Panelists
·     Mr Akshat Kshetrapal
Director Rockstart Health Accelerator
The Netherland
·     Dr Albert Tan (TBC)
Malaysia Institute for Supply Chain Innovation (MISI), Malaysia
Moderator
·     Mr. Mark Punyanitya
Co-Founder, President, CEO
PhenoMx, Inc., USA
Panelists
·     Dr. Watson Ariyaphuttarat
Bio Genetech International Co., Ltd.
·     Dr. Young Guk Cho
CEO, Global Venture Network, Korea
Moderator
·     Dr. Sarayoot Eaimkhong
Senior Consultant
Innovation and Technology Assistance Program (ITAP) National Science and Technology Development Agenc
10.40-11.00 Break 10.50-11.00 Break
11.00- 12:30 Key Session: Cancer Immunotherapy 11.00- 12:30 International Business Forum & Partnering
11.30-12.30 Precision Medicine: The Key to Success ·   Cancer immunotherapy experience in Thailand
Prof. Suradej Hongeng, MD
Department of Pediatrics
Ramathibodi Hospital, Mahidol University, Thailand
·   Haploidentical NK therapy in high risk AML
Dr. Koramit Suppipat, MD
Stem Cell and Cell Therapy Center, Faculty of Medicine, Chulalongkorn University, Thailand
·   Cellular immunotherapy for cancer
Dr. Mutita Junking, Ph.D.
Faculty of Medicine Siriraj Hospital Mahidol University, Thailand
·   Personalized Neo-antigen Vaccine
Dr. Suleepon Uttamapinan
Faculty of Medicine, Chulalongkorn University, Thailand
·   CAR-T Therapy for B-cell Malignancies
Dr. Usanarat Anurathapan, MD
Associate Professor
Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand
·   Taiwan
·   PolyAnlytik Canada
·   Kalgene, Canada
13:30–14.30 Key Session: Global Life Sciences Outlook 13:30–15.00 APEC Rare Disease Network: A Multisectoral Collaboration Solving the Challenges of Rare Diseases 13:30–16.30 Company Presentation
Mr. Joseph Damond
Executive Vice President, International Affairs, Biotechnology Innovation Organization (BIO), USA
Panelists
·     Prof Matthew Bellgard
Chair, APEC LSIF Rare Disease Network; Director, eResearch, Queensland University of Technology (QUT), Australia
·     Dr. Duangrurdee Wattanasirichaigoon, MD. (TBC)
Professor of Pediatrics, Chief of Division of Medical Genetics, Department of Pediatrics
Deputy Dean for Graduate Education
Faculty of Medicine Ramathibodi Hospital, Mahidol University
·     Prof. Vorasuk Shotelersuk (TBC)
Director, Center of Excellence for Medical Genomics, Faculty of Medicine, Chulalongkorn University, Thailand
 (15 mins each)
·     Meabco, Denmark
·     Spanish company
·     Spanish company
·     Cell DX, Thailand
·     Thonburi Hospital, Thailand
Austrianova, Thailand
“Novel technologies to allow allogeneic cell transplantation and to protect yeast and bacteria from stomach acid and environmental stress”
·     WORLDiscoveries, Canada
·     Organotechie (TBC)
14.30-14.40 Break
14:40–15.20 Thailand Life Sciences: Country Report
Mr. Pravin Krishnan
Business Development Asia-Pacific
Venture Valuation | Biotechgate, Singapore
15.20-15.40 Break 15.00-15.20  Break
15:40–16.30 Current Landscapes of Biologics Drugs in Thailand 15:20–16.30 Thailand Life Sciences Business Investment Support
Dr. Panit Kitsubun
Plant Operation Director and Research and Development Director
National Biopharmaceutical Facility, Thailand
Panelists
·     Dr. Tares Krassanairawiwong (TBC)
Secretary-General, Thai FDA
·     Mr. Chokedee Kaewsang (TBC)
Deputy Secretary General, BOI
·     Dr. Nares Damrongchai
CEO, Thailand Center of Excellence for Life Sciences
Moderator
26 September 2019
Room 213 Room 220 Room 221
9:30-10:40 Partnering Model for Medical Genomics in Southeast Asia Bio Medical Research Funding Opportunities Thailand 4.0: Becoming New API Producer from Pharmaceutical Resources
9:00 -12:00 Southeast Asia-Europe Joint Funding Scheme for Research and Innovation (SEA-EU JFS)
·   Dr. Wasun Chantratita
Ramathibodi Hospital
·   Novogene
·   Dr. Sirasak Teparkum
Deputy CEO, TCELS
MOU Signing Ceremony and Press Conference: TCELS, Ramathibodi Hospital (Mahidol University), and Novogene
At Exhibition (11.00-11.30)
·   Mr. Hans Westphal
Service Delivery Manager
The SEA-EU JFS
·   Project Ideas from 5 European Investigators
(To look for ASEAN partners to develop proposals for 4th Call)
9.30-10.00 Key Note: Open Innovation Platform for Drug Discovery and Development in ASIAN
·   Dr. Nares Damrongchai
CEO, TCELS
10.00-10.30 BIOTEC as a Collaborative Research Partner for Natural Product Drug Discovery
·   Dr. Lily Eurwilaichitr
Acting Vice President, National Science and Technology Development Agency
10.40-11.00 Break 10.30–11.00 CU as a Collaborative Research Partner for Natural Product Drug Discovery
·   TBC
11.00-12.30 Clinical Trial Landscape in Southeast Asia 11.00-12.00 Recent Perspectives on the Medicinal Potential of Ginger
“·   Dr. Suparerk Borwornpinyo
Director, Excellent Center for Drug Discovery
Panelists
•   Dr. Pairoj Jirundorn
International Advisory Committee, TCELS, Sigapore
•   Dr. Rungroj Krittayaphong
Director of National Clinical Research Center, Thailand
·   Mr. Robert Kerle, MBA,DiplBiol
Head of Research & Development Solutions in Southeast Asia, IQVIA Sigapore
Moderators
Ms. Busakorn Lerswatanasivalee,
CEO, PReMA
12:30–13.30 Lunch 12:00–13.30 Lunch 12:00–13.30 Lunch
13:30–16.30 Cell and Gene Therapy Development: Research to Market 13:30–14.50 Spain-Thailand Joint Research Funding 13.30-14.00 ·   Bridging the Gap between Drug Discovery and Clinical Development from Natural Resources
Panelsits
·   Froceth , Lithunia
·   Cryoviva Thailand (TBC)
·   Verita Care, Thailand
·   Spanish Company (TBC)
Moderator
·   TBC
·   Mr. Adrián Gutiérrez
Head of Science & Technology Department at Embassy of Spain – CDTI´s Chief Representative for India and Southeast Asia
·   Project Ideas from Spain companies
(To look for ASEAN partners to develop proposals)
·   Thailand& Spain Innovation Programme in Life Sciences Call Launching
14.00-14.30 Updated Regulatory Requirements for Pharmaceutical Registration in Thailand 4.0
·   Thai FDA (TBC)
14.30–16.30 Roundtable Discussion: Challenges in Implementing Drug Discovery and Development Industry in Thailand.
·   TBC
14.50-15.10 Break
27 September 2019
Room 213 Room 220 Room 221
9:30-10:20 Key Session: Building a Profession in Technology Transfer 9:30-12:00 Modified Drug Development and Market in Asia 9:30 – 10:30 Early Stage Investments in Life Science
·        Association of University Technology Managers (AUTM), USA MOU Signing Ceremony TCELS &NSTDA on Modified Drug Development

Key Remarks:
·   National Science and Technology Development Agency (NSTDA)
·   Thailand Center of Excellence for Life Sciences (TCELS)

Panelists
·   Dr. Sarayoot Eaimkhong
Senior Consultant
Innovation and Technology Assistance Program (ITAP) National Science and Technology Development Agency, Thaialnd
·   Prof. Dr. Garnpimol C. Ritthidej
Chulalongkorn University, Thailand
·   Korean Companie
·   Thai FDA
·   TCELS
Moderator:
TBC

TBC
10.20-10.30 Break 10.30-10.40 Break
10:30-12:00 Artificial Intelligence and Big Data in Medical Imaging 10.40-12.30 Medical Cannabis Development and Pathway to Market
Panelsits
·   Mr. Mark Punyanitya
Co-Founder, President, CEO
PhenoMx, Inc., USA
·   Neurognos, Chile
·   Chiangmai University
Moderator
TBC
·        Assoc.Prof.Dr. Neti Waranuch
·        Assoc.Prof.Dr. Kornkanok Ingkaninan
Faculty of Pharmacy, Naresuan University, Thailand
12:00–13.30 Lunch 12:30–13.30 Lunch 12:30–13.30 Lunch
13:30–14.20 Life-changing Health Solutions with AI and Nutrigenomic 13:30–16.30 Key Session: Regulatory Updates on ATMPs 13:30–16.30 Pitch & Partner
Dr. Nora Khaldi
Founder and CSO
Nuritas Company, Ireland
·        Thai FDA
·        Taiwan FDA
·        Japan FDA
·        Korea FDA
·        Malaysia FDA
Startup Pitching with Rewards
14.20-14.40 Break
14.40-16.30 Bio Medical Engineering / Medical Devices – New Industry in Asia
TBC